MyISIN

WELZIA MANAGEMENT, SGIIC, S.A.
ES0162957023A&P LIFESCIENCE FUND, FI
ES0176409003ACROPOLIS USA EQUITY, FI
ES0168356014PARADOX EQUITY FUND, FI
ES0184694034WELZIA AHORRO 5, FI
A&P LIFESCIENCE FUND, FI
•CLASE C

Valor Liquidativo

Patrimonio

Cartera Renta Variable
ActivoDiv.ValorPesoDif.
US45253H1014

ImmunoGen Inc

EUR

158.810 €

4.44%

245.62%

US38000Q1022

GlycoMimetics Inc

EUR

133.616 €

3.73%

2.94%

US16961L1061

Chinook Therapeutics

EUR

105.339 €

2.94%

Nueva

US81181C1045

Seattle Genetics Inc

EUR

79.038 €

2.21%

46.96%

US5324571083

Lilly (Eli) & Co.

EUR

73.513 €

2.05%

37.89%

US4622221004

Ionis Pharmaceutical

EUR

72.740 €

2.03%

38.18%

CH0334081137

CRISPR Therapeutics

EUR

72.304 €

2.02%

280.07%

US05464T1043

Axsome Therapeutics

EUR

70.286 €

1.96%

8.57%

US04280A1007

Arrowhead Pharmaceut

EUR

67.142 €

1.88%

36.11%

DE0006632003

Morphosys AG

EUR

66.550 €

1.86%

70.14%

US3723032062

Genmab A/S

EUR

63.553 €

1.78%

8.83%

US45665G3039

Infinity Pharmaceuti

EUR

61.089 €

1.71%

84.6%

US00847X1046

Agios Pharmaceutical

EUR

60.903 €

1.7%

49.31%

US4923271013

Keros Therapeutics I

EUR

60.699 €

1.7%

397.49%

US02043Q1076

Alnylam Pharmaceutic

EUR

60.591 €

1.69%

21.57%

US0327241065

AnaptysBio Inc

EUR

58.564 €

1.64%

107.49%

US87164F1057

Descom Inc

EUR

58.441 €

1.63%

23.03%

US00445A1007

ACELYRIN Inc

EUR

57.475 €

1.61%

Nueva

US59045L1061

Mersana Therapeutics

EUR

50.039 €

1.4%

Nueva

CH0499880968

ADC Therapeutics SA

EUR

49.407 €

1.38%

3%

US30063P1057

Exact Sciences Corp

EUR

47.600 €

1.33%

113.09%

US04016X1019

ARGENX SE

EUR

47.158 €

1.32%

0.95%

US75943R1023

Relay Therapeutics I

EUR

46.169 €

1.29%

761.52%

US0311621009

Amgen Inc.

EUR

43.350 €

1.21%

5.01%

NL0010696654

Uni-Pixel Inc.

EUR

43.102 €

1.2%

50.39%

US45337C1027

IncytCor

EUR

43.025 €

1.2%

1.64%

US24823R1059

Denali Therapeutics

EUR

40.468 €

1.13%

58.95%

US45720L1070

Inhibrx Inc

EUR

39.812 €

1.11%

64.11%

US0197701065

AllogeneTherapeutics

EUR

35.149 €

0.98%

34.61%

US60468T1051

Mirati Therapeutics

EUR

34.875 €

0.97%

19.07%

US03969F1093

Arcus Biosciences In

EUR

34.610 €

0.97%

29.08%

US50127T1097

Kura Oncology Inc

EUR

34.303 €

0.96%

Nueva

US65487U1088

Nkarta Inc

EUR

34.039 €

0.95%

32.78%

US07725L1026

Beigene ltd-adr

EUR

33.506 €

0.94%

1.93%

US52490G1022

Legend Biotech Corp

EUR

33.284 €

0.93%

38.79%

US70975L1070

Penumbra Inc

EUR

33.116 €

0.93%

69.53%

US0028241000

Abbott Laboratories

EUR

33.379 €

0.93%

30.71%

US7291391057

Pliant Therapeutics

EUR

32.373 €

0.9%

35.1%

US09077A1060

Biomea Fusion Inc

EUR

31.912 €

0.89%

155.52%

US8036071004

Sarepta Therapeutics

EUR

30.968 €

0.87%

7.64%

US1011371077

Accs. Boston Scienti

EUR

30.543 €

0.85%

19.77%

US67080M1036

Nurix Therapeutics I

EUR

29.909 €

0.84%

Nueva

US98401F1057

Xencor Inc

EUR

29.848 €

0.83%

40.88%

US76029N1063

Replimune Group Inc

EUR

29.267 €

0.82%

43.8%

US00166B1052

ALX Oncology Holding

EUR

28.845 €

0.81%

33.85%

US45166A1025

Ideaya Biosciences I

EUR

28.414 €

0.79%

90.44%

US45781K2042

Innate Pharma SA

EUR

27.818 €

0.78%

5.27%

IE00BTN1Y115

Medtronic INC

EUR

27.943 €

0.78%

40.47%

US66987V1098

NOVARTIS AG-REG SHS

EUR

27.473 €

0.77%

20.51%

US03890D1081

Aravive Inc

EUR

27.072 €

0.76%

16.36%

US92686J1060

Viking Therapeutics

EUR

27.014 €

0.75%

Nueva

US00653A1079

Adaptimmune Therapeu

EUR

25.237 €

0.71%

21.27%

US8835561023

Thermo Electron Corp

EUR

25.349 €

0.71%

7.02%

US8006771062

Sangamo Therapeutics

EUR

24.967 €

0.7%

58.38%

US00287Y1091

AbbVie Inc

EUR

24.207 €

0.68%

8.37%

US4497781090

IO Biotech Inc

EUR

23.227 €

0.65%

0.18%

US75886F1075

Regeneron Pharmaceut

EUR

23.053 €

0.64%

3.65%

US7711951043

ROCHE HOLDING

EUR

22.691 €

0.63%

4.25%

US05153U1079

Aura Biosciences Inc

EUR

22.359 €

0.62%

63.41%

US0327973006

Anavex Life Sciences

EUR

22.291 €

0.62%

40.9%

US04335A1051

Arvinas Inc

EUR

22.001 €

0.61%

5.11%

NL0010872420

Affimed NV

EUR

20.408 €

0.57%

25.87%

US09061G1013

Biostar Pharmaceutic

EUR

20.421 €

0.57%

63.71%

US68236P1075

Oncternal Therapeuti

EUR

19.710 €

0.55%

Nueva

US73730P1084

Poseida Therapeutics

EUR

19.849 €

0.55%

57.51%

US09075P1057

Bioxcel Therapeutics

EUR

19.121 €

0.53%

36.34%

US89422G1076

Travere Therapeutics

EUR

18.755 €

0.52%

Nueva

US09609G1004

Bluebird Bio Inc

EUR

18.581 €

0.52%

0.12%

US46565G1040

iTeos Therapeutics I

EUR

16.312 €

0.46%

8.64%

US40131M1099

Guardant Health Inc

EUR

15.194 €

0.42%

81.2%

US3441741077

Foghorn Therapeutics

EUR

13.984 €

0.39%

33.24%

US05280R1005

Autolus Therapeutics

EUR

11.159 €

0.31%

65.44%

US00461U1051

Aclaris Therapeutics

EUR

11.150 €

0.31%

44.8%

US4523271090

Illumina Inc

EUR

9625 €

0.27%

9%

US31189P1021

Fate Therapeutics In

EUR

8138 €

0.23%

53.71%

US09077B1044

BioAtla Inc

EUR

7202 €

0.2%

45.89%

US28106W1036

Edit-Me

EUR

7076 €

0.2%

53.33%

US0887861088

Bicycle Therapeutics

EUR

6503 €

0.18%

18.78%

US14147L1089

Cardiff Oncology Inc

EUR

6359 €

0.18%

54.23%

US75082Q1058

Rain Oncology Inc

EUR

4734 €

0.13%

Nueva

US46124U1079

Inventiva SACA

EUR

4748 €

0.13%

90.22%

US45175G1085

Ikena Oncology Inc

EUR

4378 €

0.12%

142.01%

US55910K1088

Magenta Therapeutics

EUR

4370 €

0.12%

88.28%

US0076244062

Advaxis Inc

EUR

2369 €

0.07%

Nueva

US7027121000

Passage Bio Inc

EUR

2244 €

0.06%

10.67%

US1894641000

Clovis Oncology Inc

EUR

201 €

0.01%

78.22%

US05465V1089

Ayala Pharmaceutical

EUR

0 €

0%

Vendida

IL0010852080

Compugen Ltd

EUR

0 €

0%

Vendida

Cartera ICC
ActivoDiv.ValorPesoDif.
IE00BQ70R696

Invesco NASDAQ Biote

EUR

155.184 €

4.34%

Nueva

IE00BQ70R696

ETFEner

EUR

0 €

0%

Vendida

Fondo
Informe

2023-Q2

Inversión

Renta Variable Internacional

Riesgo
Divisa

EUR

Nº de Participaciones

0

Nº de Partícipes

0

Beneficios Distribuidos

0

Inversión mínima

Patrimonio

0 €

Valor Liquidativo

0 €

Politica de inversiónEl fondo invertirá más del 75% de la exposición total en Renta Variable, tanto directa o indirectamente, habitualmente en más de 20 títulos, que mayoritariamente pertenecerán al sector biotecnológico y de la salud (pequeñas empresas de fármacos innovadores o "biotechs", empresas de genéricos, grandes empresas farmacéuticas, de dispositivos médicos, de servicios hospitalarios y/o aseguradoras etc.). Las inversiones se centrarán en emisores/mercados OCDE, pudiendo invertir hasta un 30% en emisores/mercados no OCDE, incluyendo emergentes, y sin predeterminación de capitalización bursátil mínima, siendo mayoritariamente de pequeña y mediana capitalización.
Operativa con derivadosSe podrá operar con instrumentos financieros derivados negociados en mercados organizados y no organizados de derivados con la finalidad de cobertura y de inversión.

Sectores

  • Salud

    98.12%

  • No Clasificado

    1.88%

Regiones

  • Estados Unidos

    90.84%

  • Europa

    9.16%

Tipo de Inversión

  • Small Cap - Growth

    25.41%

  • Small Cap - Value

    23.07%

  • Small Cap - Blend

    15.81%

  • Medium Cap - Growth

    10.17%

  • Large Cap - Growth

    6.32%

  • Large Cap - Blend

    6.01%

  • Medium Cap - Value

    2.37%

  • Medium Cap - Blend

    2.00%

  • Large Cap - Value

    1.71%

  • No Clasificado

    7.15%

Comisiones

Comisión de gestión

Total
2023-Q2

0.00

Comisión de depositario

Total
2023-Q2

0.00